Literature DB >> 10051632

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.

I S Misko1, S M Cross, R Khanna, S L Elliott, C Schmidt, S J Pye, S L Silins.   

Abstract

The immunodominant, CD8(+) cytotoxic T lymphocyte (CTL) response to the HLA-B8-restricted peptide, RAKFKQLL, located in the Epstein-Barr virus immediate-early antigen, BZLF1, is characterized by a diverse T cell receptor (TCR) repertoire. Here, we show that this diversity can be partitioned on the basis of crossreactive cytotoxicity patterns involving the recognition of a self peptide-RSKFRQIV-located in a serine/threonine kinase and a bacterial peptide-RRKYKQII-located in Staphylococcus aureus replication initiation protein. Thus CTL clones that recognized the viral, self, and bacterial peptides expressed a highly restricted alphabeta TCR phenotype. The CTL clones that recognized viral and self peptides were more oligoclonal, whereas clones that strictly recognized the viral peptide displayed a diverse TCR profile. Interestingly, the self and bacterial peptides equally were substantially less effective than the cognate viral peptide in sensitizing target cell lysis, and also resulted only in a weak reactivation of memory CTLs in limiting dilution assays, whereas the cognate peptide was highly immunogenic. The described crossreactions show that human antiviral, CD8(+) CTL responses can be shaped by peptide ligands derived from autoantigens and environmental bacterial antigens, thereby providing a firm structural basis for molecular mimicry involving class I-restricted CTLs in the pathogenesis of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051632      PMCID: PMC26774          DOI: 10.1073/pnas.96.5.2279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.

Authors:  V Levitsky; P O de Campos-Lima; T Frisan; M G Masucci
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

2.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells.

Authors:  M J Bevan
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Molecular mimicry and autoimmune disease.

Authors:  M B Oldstone
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

Review 5.  Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families.

Authors:  R K Wilson; E Lai; P Concannon; R K Barth; L E Hood
Journal:  Immunol Rev       Date:  1988-01       Impact factor: 12.988

Review 6.  The normal microbial flora.

Authors:  P A Mackowiak
Journal:  N Engl J Med       Date:  1982-07-08       Impact factor: 91.245

7.  Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.

Authors:  N S Prang; M W Hornef; M Jäger; H J Wagner; H Wolf; F M Schwarzmann
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

8.  HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies.

Authors:  I S Misko; J H Pope; R Hütter; T D Soszynski; R G Kane
Journal:  Int J Cancer       Date:  1984-02-15       Impact factor: 7.396

9.  Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Authors:  M Rowe; D T Rowe; C D Gregory; L S Young; P J Farrell; H Rupani; A B Rickinson
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

10.  Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.

Authors:  S L Silins; S M Cross; S L Elliott; S J Pye; S R Burrows; J M Burrows; D J Moss; V P Argaet; I S Misko
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  19 in total

1.  CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

Authors:  M F Callan; C Fazou; H Yang; T Rostron; K Poon; C Hatton; A J McMichael
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Multiple T-cell clones specific for the same foreign pMHC ligand can be generated from a single, ancestral TCR-VDJbeta precursor.

Authors:  Janet L Maryanski; Anne Aublin; Valérie Attuil-Audenis; Abdelbasset Hamrouni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Authors:  Shalyn C Clute; Levi B Watkin; Markus Cornberg; Yuri N Naumov; John L Sullivan; Katherine Luzuriaga; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 5.  T-cell memory: lessons from Epstein-Barr virus infection in man.

Authors:  A B Rickinson; M F Callan; N E Annels
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

6.  Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30.

Authors:  R D Mason; M I Bowmer; C M Howley; M D Grant
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 7.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

8.  Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

Authors:  G V Gregorio; K Choudhuri; Y Ma; P Pensati; R Iorio; P Grant; J Garson; D P Bogdanos; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Authors:  Katja Nilges; Hanni Höhn; Henryk Pilch; Claudia Neukirch; Kirsten Freitag; P J Talbot; Markus J Maeurer
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Inducing efficient cross-priming using antigen-coated yeast particles.

Authors:  Shanshan W Howland; Takemasa Tsuji; Sacha Gnjatic; Gerd Ritter; Lloyd J Old; Karl Dane Wittrup
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.